Dark

MCRB
Seres Therapeutics, Inc.
stock NASDAQ

At Close

Oct 1, 2026 3:59:31 PM EDT

2.91USD-12.985%(-0.44)247,310

0.00Bid 0.00Ask 0.00Spread

Pre-market

Oct 1, 2026 9:28:30 AM EDT

3.10USD-7.463%(-0.25)4,775

After-hours

Oct 1, 2026 4:12:30 PM EDT

2.93USD+0.515%(+0.02)366

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

29.28M

Headquarters

Cambridge, Massachusetts, USA

Industry

Biotechnology

Next Earnings

Nov 4, 2026 (33d)

Last Split

Apr 22, 20251for20reverse

XLRN XNCR BLCM XON XLV

MCRB Stats

Avg. Vol. 10 Day

59,235

Avg. Vol. 30 Day

58,327

Employees

138

Market Cap

29,280,537

Shares Out.

10,044,781

On/Off Exchange

60%/40%

6 Month Beta

0.98

1 Year Beta

1.26

2 Year Beta

1.16

3 Year Beta

1.11

52 Week Low

3.26

52 Week High

29.98

SMA50

4.68

SMA200

8.54

1 Week

-19.48%

1 Month

-43.73%

3 Month

-63.29%

6 Month

-67.10%

1 Year

-85.78%

2 Year

-84.84%

5 Year

-97.99%

Profile

seres therapeutics is a clinical stage biotherapeutic company focused on discovering and developing ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. founded by flagship venturelabs, seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. current candidates span infectious, metabolic, and inflammatory diseases. for more information, please visit http://serestherapeutics.com/.

MCRB Stock Summary

Seres Therapeutics, Inc. (NASDAQ:MCRB) stock price today is $2.91, and today's volume is 247,310. MCRB is down -12.985% today. The 30 day average volume is 58,327. MCRB market cap is 29.28M with 10,044,781 shares outstanding.